Published
2025-11-06
Section
Research Articles
License
Copyright (c) 2025 Çağla Gür

This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal adopts the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which means that anyone can reuse and redistribute the materials for non-commercial purposes as long as you follow the license terms and the original source is properly cited.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher rights for the first publication with the work concurrently licensed since 2023 Vol.8 No.2.
Under this license, author(s) will allow third parties to download, reuse, reprint, modify, distribute and/or copy the content under the condition that the authors are given credit. No permission is required from the authors or the publisher.
This broad license intends to facilitate free access, as well as the unrestricted use of original works of all types. This ensures that the published work is freely and openly available in perpetuity.
By providing open access, the following benefits are brought about:
- Higher Visibility, Availability and Citations-free and unlimited accessibility of the publication over the internet without any restrictions increases citation of the article.
- Ease of search-publications are easily searchable in search engines and indexing databases.
- Rapid Publication – accepted papers are immediately published online.
- Available for free download immediately after publication at https://esp.as-pub.com/index.php/ESP

Copyright Statement
1.The authors certify that the submitted manuscripts are original works, do not infringe the rights of others, are free from academic misconduct and confidentiality issues, and that there are no disputes over the authorship scheme of the collaborative articles. In case of infringement, academic misconduct and confidentiality issues, as well as disputes over the authorship scheme, all responsibilities will be borne by the authors.
2. The author agrees to grant the Editorial Office of Environment and Social Psychology a licence to use the reproduction right, distribution right, information network dissemination right, performance right, translation right, and compilation right of the submitted manuscript, including the work as a whole, as well as the diagrams, tables, abstracts, and any other parts that can be extracted from the work and used in accordance with the characteristics of the journal. The Editorial Board of Environment and Social Psychology has the right to use and sub-licence the above mentioned works for wide dissemination in print, electronic and online versions, and, in accordance with the characteristics of the periodical, for the period of legal protection of the property right of the copyright in the work, and for the territorial scope of the work throughout the world.
3. The authors are entitled to the copyright of their works under the relevant laws of Singapore, provided that they do not exercise their rights in a manner prejudicial to the interests of the Journal.
About Licence
Environment and Social Psychology is an open access journal and all published work is available under the Creative Commons Licence, Authors shall retain copyright of their work and grant the journal/publisher the right of first publication, and their work shall be licensed under the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).
Under this licence, the author grants permission to third parties to download, reuse, reprint, modify, distribute and/or copy the content with attribution to the author. No permission from the author or publisher is required.
This broad licence is intended to facilitate free access to and unrestricted use of original works of all kinds. This ensures that published works remain free and accessible in perpetuity. Submitted manuscripts, once accepted, are immediately available to the public and permanently accessible free of charge on the journal’s official website (https://esp.as-pub.com/index.php/ESP). Allowing users to read, download, copy, print, search for or link to the full text of the article, or use it for other legal purposes. However, the use of the work must retain the author's signature, be limited to non-commercial purposes, and not be interpretative.
Click to download <Agreement on the Licence for the Use of Copyright on Environmental and Social Psychology>.
How to Cite
The silent footsteps of danger: A qualitative study of methamphetamine use disorder
Çağla Gür
Faculty of Education, Cyprus International University, 99258, Nicosia, Cyprus
DOI: https://doi.org/10.59429/esp.v10i10.4148
Keywords: adolescents and young adults; childhood; psychiatric manifestations; social determinants of health; family dynamics; public mental health
Abstract
Methamphetamine use disorder represents a growing global health concern, particularly affecting adolescents and young adults. Beyond its well-established neurotoxic effects, the substance imposes severe psychosocial consequences on individuals, families, and broader communities. This study aimed to provide a multidimensional understanding of methamphetamine dependence by combining psychiatric expertise with the lived experiences of an affected family. A qualitative design was employed, drawing on semi-structured interviews with 21 psychiatrists working in adult psychiatry departments and with members of a family directly impacted by methamphetamine addiction. Thematic analysis identified four overarching domains: (1) perceived trends in use, (2) psychiatric manifestations and diagnostic challenges, (3) social and environmental determinants, and (4) approaches to treatment and prevention. Findings demonstrated a marked increase in methamphetamine use among adolescents and young adults, with both clinicians and family members emphasizing the rapid transition from experimentation to dependence. Prominent psychiatric outcomes observed in methamphetamine dependence included intense paranoia, vivid hallucinations, episodes of aggression, and long-lasting cognitive deficits. These symptoms frequently made it challenging for clinicians to distinguish substance-induced states from primary psychotic illnesses. Beyond clinical manifestations, contextual influences played a critical role. Economic hardship, strained family relationships, parental mental health problems, and broader global uncertainties were repeatedly described as factors that heightened vulnerability. Excessive engagement with digital platforms and the anxiety provoked by constant exposure to social media further intensified these risks, while stigma and cultural silence often postponed both recognition of the problem and access to care. Importantly, the findings suggest that successful responses cannot rely on medication alone. The establishment of trusting therapeutic relationships, the introduction of preventive education during adolescence, the development of coping and problem-solving skills, and coordinated work across medical, psychological, and social domains emerged as vital elements of effective care. Taken together, these insights point to the need to approach Methamphetamine use disorder not only as a neuropsychiatric condition but also as a broader social phenomenon, one that demands integrated strategies spanning clinical practice, family systems, and community support structures.
References
[1]. 1.Cruickshank, C. C., & Dyer, K. R. A review of the clinical pharmacology of methamphetamine. Addiction Research & Theory, 2009, 104(7): 1085–1099. https://doi.org/10.1111/j.1360-0443.2009.02564.x
[2]. 2.Darke, S., Duflou,J, & Torok,M.. Comparative toxicology of fatal methadone and heroin toxicity cases. Drug and Alcohol Dependence, 2010, 6(1): 1-6. https://doi.org/10.1016/j.drugalcdep.2009.07.014
[3]. 3.United Nations Office on Drugs and Crime (UNODC). World Drug Report 2023. United Nations Publications, 2023.Available at: https://doi.org/10.18356/9789210028233c001 (Accessed on 09.09.2025)
[4]. 4.Trucco, E. M. A review of psychosocial factors linked to adolescent substance use. Pharmacology, Biochemistry and Behavior, 2020, 196: 172969. https://doi.org/10.1016/j.pbb.2020.172969
[5]. 5.Conway, F. N., Samora, J., Brinkley, K., Jeong, H., Clinton, N., & Claborn, K. R. Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs. Harm Reduction Journal, 2022, 19: 72. https://doi.org/10.1186/s12954-022-00653-1 https://www.tandfonline.com/doi/full/10.1080/09687637.2021.1891945
[6]. 6.Dubey, M. J., Ghosh, R., Chatterjee, S., Biswas, P., Chatterjee, S., & Dubey, S. COVID-19 and addiction. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020, 14(5): 817–823. https://doi.org/10.1016/j.dsx.2020.06.008
[7]. 7.Sharma, B., Kumar, P., & Sharma, P. Smartphone is it “behaviour addiction or substance abuse disorder”: a review to find chemistry behind. International Journal of Pharmaceutical Sciences and Research, 2021,12(1), 1000- 1008. http://dx.doi.org/10.13040/IJPSR.0975-8232.12(1).1000-08
[8]. 8.Maina, G., Ogenchuk, M., Phaneuf, T., & Kwame, A. “I can’t live like that”: The experience of caregiver stress of caring for a relative with substance use disorder. Substance Abuse Treatment, Prevention, and Policy, 2021, 16: 11. https://doi.org/10.1186/s13011-021-00344-3
[9]. 9.Gronholm, P. C., Kline, S., Lamba, M., Lempp, H., Mahkmud, A., Cano, G. M., & Sunkel, C. Exploring perspectives of stigma and discrimination among people with lived experience of mental health conditions: A co- produced qualitative study. EClinicalMedicine, 2024,70, 102499.
[10]. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00088-9/fulltext
[11]. 10.Hawke, L. D., Sheikhan, N. Y., Roberts, S., & McKee, S. Research evidence and implementation gaps in the engagement of people with lived experience in mental health and substance use research: a scoping review. Research Involvement and Engagement, 2023, 9(1), 32. https://doi.org/10.1186/s40900-023-00442-5
[12]. 11.Edinoff, A.N., Kaufman, S.E., Green, K.M., Provenzano, D.A., Lawson, J., Cornett, E.M. & Kaye, A.D. Methamphetamine use: a narrative review of adverse effects and related toxicities. Health Psychology Resource, 2022,10(3):38161. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476235/
[13]. 12.Liu, G. X. H., Tayebi, M., Bristow, B., Wang, J., Lin, Y., Newburn, G.,& Scadeng, M. How does methamphetamine affect the brain? A systematic review of magnetic resonance imaging studies. medRxiv, 2025, 02. https://doi.org/10.1101/2025.02.11.25322099
[14]. 13.Whitesell, M., Bachand, A., Peel, J., & Brown, M. Familial, social, and individual factors contributing to risk for adolescent substance use. Journal of addiction, 2013,1:579310. http://dx.doi.org/10.1155/2013/579310 Journal of Social Issues, 2021, 77(4): 913–933. https://doi.org/10.1111/josi.12449
[15]. 14.Morse, S. C., Fockele, C., Huynh, L. N., Zatzick, A., & Whiteside, L. K. (2023). A qualitative study of people who use methamphetamine during the early COVID-19 pandemic to inform future ED harm reduction strategies. International Journal of Emergency Medicine, 2023, 16(1): 30. https://doi.org/10.1186/s12245-023-00505-0
[16]. 15.Kuss, D. J., & Pontes, H. M. Internet addiction. Hogrefe Publishing, 2018, pp.5-12.
[17]. 16.Glasner-Edwards, S., & Mooney, L. J. Methamphetamine psychosis: epidemiology and management. CNS Drugs, 2014, 28(12): 1115-1126. https://doi:10.1007/s40263-014-0209-8.
[18]. 17.Kalhovde, A. M., & Kitzmüller, G. Family caregivers’ trajectories of distress while caring for a person with serious mental illness. Qualitative Health Research, 2024, 34(1-2):154-165.
[19]. https://doi.org/10.1177/10497323231203627
[20]. 18.Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction, 2012,107(1), 39-50.
[21]. https://doi.org/10.1111/j.1360-0443.2011.03601.x
[22]. 19.United Nations Office on Drugs and Crime (UNODC). World Drug Report 2024. United Nations Publications, 2024. Available at: https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html (Accessed on 09.09.2025)
[23]. 20.Xing, D.G., Mohiuddin, F., Bhuiyan, M.S., Hossain, M.I., Al-Yafeai,Z., Faisal, A.S.M, Goeders, N.E.,& Bhuiyan, M.A.N. Prevalence and patterns of methamphetamine use and mental health disparity in the United States. Nat Ment Health,2024 ,2:951-959. https://doi.org/10.1038/s44220-024-00282-6
[24]. 21.Nowell, L. S., Norris, J. M., White, D. E., & Moules, N. J. Thematic analysis: Striving to meet the trustworthiness criteria. International Journal of Qualitative Methods, 2024,16(1): 1609406917733847
[25]. https://doi.org/10.1177/1609406917733847
[26]. 22.Brinkmann, S., & Kvale, S. Doing Interviews (2nd ed.). SAGE Publications, 2018. https://us.sagepub.com/en- us/nam/doing-interviews/book259685
[27]. 23.Braun, V., & Clarke, V. Thematic analysis: A practical guide. SAGE Publications, 2022.
[28]. https://us.sagepub.com/en-us/nam/thematic-analysis/book275202
[29]. 24.Rockhill, C. M., Ramtekkar, U., Becker, T. D., Greenhill, L., Hayek, M., Vasa, R. A.,& Walter, H. J. Clinical practice guideline: Assessment and treatment of adolescents and young adults with substance use disorders and problematic substance use. Journal of the American Academy of Child & Adolescent Psychiatry,2025, JAAC 5256. https://doi.org/10.1016/j.jaac.2025.08.006
[30]. 25.Son, Y., Hong, S., Yim, Y., Kim, S., Lee, H., Lee, K.,& Kang, J. Global prevalence of cannabis and amphetamine/methamphetamine use among adolescents in 47 countries: a population-based study from WHO database. World Journal of Pediatrics, 2025,21(3), 291-305. https://doi.org/10.1007/s12519-025-00883-w
[31]. 26.Hemphill, K., Tierney, S., Tirschwell, D., & Davis, A. P. A review of methamphetamine use and stroke in the young. Frontiers in Neurology, 2024,15, 1397677. https://doi.org/10.3389/fneur.2024.1397677
[32]. 27.Wearne, T. A., & Cornish, J. L. A comparison of methamphetamine-induced psychosis and schizophrenia: A review of positive, negative, and cognitive symptomatology. Frontiers in Psychiatry, 2018, 9: 491. https://doi.org/10.3389/fpsyt.2018.00491
[33]. 28.Belfiore, C. I., Galofaro, V., Cotroneo, D., Lopis, A., Tringali, I., Denaro, V., & Casu, M. A multi-level analysis of biological, social, and psychological determinants of substance use disorder and co-occurring mental health outcomes. Psychoactives, 2024, 3(2):194-214. https://www.mdpi.com/2813-1851/3/2/13#
[34]. 29.Sevari, K., & Terahi, R. Comparison of family functioning, social support and irrational beliefs in addicted addicts undergoing compulsory treatment and self-reported addicts in treatment centers. Social Psychology Research, 2024, 13(52), 85-98. https://doi.org/10.22034/spr.2024.432563.1900
[35]. 30.Khalaf, A. M., Alubied, A. A., Khalaf, A. M., & Rifaey, A. A. The impact of social media on the mental health of adolescents and young adults: A systematic review. Cureus, 2023, 15(8): e42990.
[36]. https://doi.org/10.7759/cureus.42990
[37]. 31.El Hayek, S., Foad, W., De Filippis, R., Ghosh, A., Koukach, N., Mahgoub Mohammed Khier, A.,& Shalbafan, M. (2024). Stigma toward substance use disorders: A multinational perspective and call for action. Frontiers in Psychiatry, 2024,15, 1295818. https://doi.org/10.3389/fpsyt.2024.1295818
[38]. 32.Magill, M., Martino, S., & Wampold, B. E. Defining the therapeutic relationship in the context of alcohol use, other drug use, and behavior change: Principles and practices. Journal of Substance Use and Addiction Treatment, 2024,163, 209398. https://doi.org/10.1016/j.josat.2024.209398
[39]. 33.Becker, T. D., Castañeda Ramirez, S., Bruges Boude, A., Leong, A., Ivanov, I., & Rice, T. R. Interventions for prevention and treatment of substance use in youth with traumatic childhood experiences: a systematic review and synthesis of the literature. European Child & Adolescent Psychiatry, 2024, 33(10), 3419-3438.
[40]. 34.Remskar, M., Western, M. J., Osborne, E. L., Maynard, O. M., & Ainsworth, B. Effects of combining physical activity with mindfulness on mental health and wellbeing: Systematic review of complex interventions. Mental health and physical activity, 2024, 26:100575. https://doi.org/10.1016/j.mhpa.2023.100575
[41]. 35.Marx, W., Manger, S. H., Blencowe, M., Murray, G., Ho, F. Y. Y., Lawn, S.,& O’Neil, A. Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce. The World Journal of Biological Psychiatry, 2023, 24(5):333-386. https://doi.org/10.1080/15622975.2022.2112074
[42]. 36.Gür, Ç., & Eser, B. Who? What? How? From a standard teacher meeting to a preschool positive thinking project. SAGE Open, 2022, 12(4), 1–18. https://doi.org/10.1177/21582440221133998
[43]. 37.Gür,Ç. İyi oluş ve pozitif düşünme [Well-being and positive thinking]. In Bebeklikten ergenliğe iyi oluş: Pozitif düşünme eğitimi [Well-Being from Infancy to Adolescence: Positive Thinking Education], 3rd edition (Ed.Ç.Gür), Anı Publishing. 2023.pp:1-52






